Ballentine Partners, LLC Biogen Inc. Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 1,529 shares of BIIB stock, worth $223,952. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,529
Previous 3,334 54.14%
Holding current value
$223,952
Previous $772,000 61.66%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$189.07 - $236.8 $341,271 - $427,424
-1,805 Reduced 54.14%
1,529 $296,000
Q2 2024

Aug 06, 2024
BUY
$190.52 - $236.72 $317,596 - $394,612
1,667 Added 100.0%
3,334 $772,000
Q1 2024

Apr 11, 2024
BUY
$212.02 - $267.71 $3,816 - $4,818
18 Added 1.09%
1,667 $359,000
Q4 2023

Jan 23, 2024
BUY
$222.59 - $267.94 $26,933 - $32,420
121 Added 7.92%
1,649 $426,000
Q3 2023

Oct 19, 2023
BUY
$253.3 - $285.89 $12,158 - $13,722
48 Added 3.24%
1,528 $392,000
Q2 2023

Jul 26, 2023
BUY
$275.25 - $318.06 $16,239 - $18,765
59 Added 4.15%
1,480 $421,000
Q1 2023

Apr 27, 2023
SELL
$256.56 - $292.34 $15,393 - $17,540
-60 Reduced 4.05%
1,421 $395,000
Q4 2022

Jan 27, 2023
SELL
$252.44 - $306.72 $252 - $306
-1 Reduced 0.07%
1,481 $0
Q3 2022

Oct 26, 2022
BUY
$194.69 - $268.46 $59,769 - $82,417
307 Added 26.13%
1,482 $395,000
Q2 2022

Aug 09, 2022
SELL
$187.54 - $223.02 $13,315 - $15,834
-71 Reduced 5.7%
1,175 $241,000
Q1 2022

May 05, 2022
SELL
$193.77 - $244.14 $14,920 - $18,798
-77 Reduced 5.82%
1,246 $263,000
Q4 2021

Feb 14, 2022
BUY
$223.92 - $287.77 $38,514 - $49,496
172 Added 14.94%
1,323 $317,000
Q3 2021

Oct 27, 2021
SELL
$282.99 - $369.05 $45,844 - $59,786
-162 Reduced 12.34%
1,151 $326,000
Q2 2021

Aug 12, 2021
SELL
$259.0 - $414.71 $25,123 - $40,226
-97 Reduced 6.88%
1,313 $454,000
Q1 2021

May 11, 2021
SELL
$242.95 - $284.63 $9,475 - $11,100
-39 Reduced 2.69%
1,410 $395,000
Q4 2020

Jan 25, 2021
SELL
$236.26 - $355.63 $906,057 - $1.36 Million
-3,835 Reduced 72.58%
1,449 $355,000
Q3 2020

Oct 22, 2020
SELL
$264.77 - $305.71 $437,135 - $504,727
-1,651 Reduced 23.81%
5,284 $1.5 Million
Q2 2020

Jul 31, 2020
SELL
$258.66 - $342.55 $13,967 - $18,497
-54 Reduced 0.77%
6,935 $1.86 Million
Q1 2020

Apr 23, 2020
BUY
$268.85 - $341.04 $15,593 - $19,780
58 Added 0.84%
6,989 $2.21 Million
Q4 2019

Jan 22, 2020
BUY
$220.06 - $304.07 $1.08 Million - $1.5 Million
4,918 Added 244.31%
6,931 $2.06 Million
Q3 2019

Oct 21, 2019
BUY
$217.44 - $243.88 $10,437 - $11,706
48 Added 2.44%
2,013 $468,000
Q2 2019

Jul 25, 2019
BUY
$219.29 - $241.72 $5,043 - $5,559
23 Added 1.18%
1,965 $460,000
Q1 2019

May 09, 2019
SELL
$216.71 - $338.96 $1,516 - $2,372
-7 Reduced 0.36%
1,942 $459,000
Q4 2018

Feb 04, 2019
SELL
$278.5 - $352.75 $77,423 - $98,064
-278 Reduced 12.48%
1,949 $587,000
Q3 2018

Oct 30, 2018
SELL
$293.51 - $383.83 $550,918 - $720,448
-1,877 Reduced 45.74%
2,227 $787,000
Q2 2018

Jul 19, 2018
BUY
$257.52 - $306.91 $14,421 - $17,186
56 Added 1.38%
4,104 $1.19 Million
Q1 2018

Apr 26, 2018
BUY
$260.13 - $367.91 $564,742 - $798,732
2,171 Added 115.66%
4,048 $1.11 Million
Q4 2017

Feb 02, 2018
BUY
$307.64 - $344.58 $62,143 - $69,605
202 Added 12.06%
1,877 $598,000
Q3 2017

Nov 06, 2017
BUY
$281.15 - $329.69 $470,926 - $552,230
1,675
1,675 $525,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email